Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.

  • Leung D
  • Chu E
  • Wood N
  • et al.
105Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

We recently demonstrated that during the acute phase of mucocutaneous lymph node syndrome (MCLS)3 there was a significant reduction in circulating T8+ suppressor/cytotoxic T cells and an increased number of Ia/Dr-bearing T4+ T cells, which suggests the presence of circulating activated helper T cells (1). Furthermore, the vast majority of patients with acute MCLS had a significantly elevated number of circulating B cells spontaneously secreting IgG and IgM. In the present study, the possible role of the immunoregulatory T cell abnormalities in the polyclonal B cell activation was investigated by assaying the ability of T cells and T cell factors from patients with acute MCLS to induce immunoglobulin production by normal B lymphocytes. We also examined the capacity of normal T cells to suppress immunoglobulin production by activated B cells from patients with acute MCLS.

Cite

CITATION STYLE

APA

Leung, D. Y., Chu, E. T., Wood, N., Grady, S., Meade, R., & Geha, R. S. (1983). Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. The Journal of Immunology, 130(5), 2002–2004. https://doi.org/10.4049/jimmunol.130.5.2002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free